{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cameroon", "antiviral agents", "hepatitis C", "prevalence", "public health"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28191540", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "12", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1515/jtim-2016-0037"], "Journal": {"ISSN": "2450-131X", "JournalIssue": {"Volume": "4", "Issue": "4", "PubDate": {"Year": "2016", "Month": "Dec", "Day": "01"}}, "Title": "Journal of translational internal medicine", "ISOAbbreviation": "J Transl Int Med"}, "ArticleTitle": "Hepatitis C in Cameroon: What is the progress from 2001 to 2016?", "Pagination": {"StartPage": "162", "EndPage": "169", "MedlinePgn": "162-169"}, "Abstract": {"AbstractText": ["Chronic hepatitis C is a major public health problem in sub-Saharan countries and particularly in Cameroon where the prevalence rate is around 7.6% in the age group of 55-59 years. Recent investigations into this infection allowed defining a national seroprevalence, characterizing virological and biological profiles of infected patients and identifying medicinal plants of potential interest in hepatitis C therapy. However, in Cameroon, no existing report currently presents a good overview of hepatitis C research in relation to these parameters. This review seeks to discuss major findings published since 2001 that have significantly advanced our understanding of the epidemiology and treatment of hepatitis C in Cameroonian patients and highlight the major challenges that remain to overcome. We performed a systematic search in Pubmed and Google Scholar. Studies evaluating prevalence, treatment, coinfection, and genetic diversity of HCV infection in Cameroon were included. Studies suggest that HCV prevalence in Cameroon would be low (around 1.1%) with a lot of disparities according to regions and age of participants. Elders, pregnant women, blood donors, health care workers, patients on hemodialysis, and homozygous sickle cell patients have been identified as risk groups. Moreover, HCV/HBV coinfection was found more prevalent than HCV/HIV coinfection. Phylogenic studies reported circulation of three main genotypes such genotypes 1, 2, and 4 but little is known about antiviral candidates from the Cameroonian pharmacopeia. In conclusion, some epidemiological data prove that hepatitis C in Cameroon is well known but efforts are still necessary to prevent or control this infection."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Applied Biochemistry, Department of Biological Sciences, Faculty of Science, University of Ngaoundere, PO Box 454 Ngaoundere, Ngaoundere, Cameroon, Cameroon; Laboratory of Pharmacology and Toxicology, Department of Biochemistry, Faculty of Science, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon."}], "LastName": "Tietcheu Galani", "ForeName": "Borris Rosnay", "Initials": "BR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology Unit, Centre Pasteur du Cameroun, Yaound\u00e9, Cameroun."}], "LastName": "Njouom", "ForeName": "Richard", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacology and Toxicology, Department of Biochemistry, Faculty of Science, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon."}], "LastName": "Moundipa", "ForeName": "Paul Fewou", "Initials": "PF", "Suffix": "PhD"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Poland", "MedlineTA": "J Transl Int Med", "NlmUniqueID": "101673826", "ISSNLinking": "2224-4018"}, "CoiStatement": "Authors declare no conflict of interests for this manuscript."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST.. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333\u201342.", "ArticleIdList": ["23172780"]}, {"Citation": "Nerrienet E, Pouillot R, Lachenal G, Njouom R, Mfoupouendoun J, Bilong C. et al. Hepatitis C virus infection in cameroon: A cohort-effect. J Med Virol. 2005;76:208\u201314.", "ArticleIdList": ["15834878"]}, {"Citation": "Njouom R, Tejiokem MC, Texier G, Fontanet A.. O-02: Prevalence of hepatitis B, hepatitis C and hepatitis D virus infections in Cameroon: results from a national population based survey (The ANRS 12289 project) J Viral Hepat. 2015;22:1\u20132."}, {"Citation": "Li C, Njouom R, Pepin J, Nakano T, Bennett P, Pybus OG. et al. Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1. J Gen Virol. 2013;94:1780\u201390.", "ArticleIdList": ["PMC3749522", "23677792"]}, {"Citation": "Andoulo FA, Noah DN, Djapa R, Kowo M, Talla P, Medjo EH. et al. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon. Pan Afr Med J. 2014;19:379.", "ArticleIdList": ["PMC4427468", "25977742"]}, {"Citation": "P\u00e9pin J, Lavoie M, Pybus OG, Pouillot R, Foupouapouognigni Y, Rousset D. et al. Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis. 2010;51:768\u201376.", "ArticleIdList": ["20735242"]}, {"Citation": "Njouom R, Pasquier C, Ayouba A, Gessain A, Froment A, Mfoupouendoun J. et al. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol. 2003;71:219\u201325.", "ArticleIdList": ["12938196"]}, {"Citation": "Njouom R, Pasquier C, Ayouba A, Sandres-Saun\u00e9 K, Mfoupouendoun J, Mony Lobe M. et al. Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes. J Med Virol. 2003;69:384\u201390.", "ArticleIdList": ["12526049"]}, {"Citation": "Njouom R, Pasquier C, Ayouba A, Tejiokem MC, Vessiere A, Mfoupouendoun J. et al. Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg. 2005;73:460\u20136.", "ArticleIdList": ["16103623"]}, {"Citation": "Noubiap JJN, Joko WYA, Nansseu JRN, Tene UG, Siaka C.. Seroepidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Ed\u00e9a, Cameroon. Int J Infec Dis. 2013;17:e832\u20137.", "ArticleIdList": ["23317526"]}, {"Citation": "Eboumbou Moukoko CE, Ngo Sack F, Essangui Same EG, Mbangue M, Lehman LG.. HIV, HBV, HCV and T. pallidum infections among blood donors and Transfusion-related complications among recipients at the Laquintinie hospital in Douala, Cameroon. BMC Hematol. 2014;14:5.", "ArticleIdList": ["PMC3944961", "24517107"]}, {"Citation": "Mbanya DN, Takam D, Ndumbe PM.. Serological findings amongst first-time blood donors in Yaound\u00e9, Cameroon: is safe donation a reality or a myth? Transfus Med. 2013;13:267\u201373.", "ArticleIdList": ["14617337"]}, {"Citation": "Ankouane F, Noah Noah D, Atangana MM, Kamgaing Simo R, Guekam PR. et al. Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaound\u00e9 Central Hospital in the centre region of Cameroon. Transfus Clin Biol. 2016;23:72\u20137.", "ArticleIdList": ["26791918"]}, {"Citation": "Noubiap JJN, Aka PV, Nanfack AJ, Agyingi LA, Ngai JN, Nyambi PN.. Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade. PloS One. 2015;10:1\u201314.", "ArticleIdList": ["PMC4570762", "26371878"]}, {"Citation": "Ymele FF, Keugoung B, Fouedjio JH, Kouam N, Mendibi S, Dongtsa Mabou J.. High Rates of Hepatitis B and C and HIV Infections among Blood Donors in Cameroon: A Proposed Blood Screening Algorithm for Blood Donors in Resource-Limited Settings. J Blood Transfus. 2012;2012:1\u20137.", "ArticleIdList": ["PMC3771127", "24066258"]}, {"Citation": "Birguel J, Ndong JG, Akhavan S, Moreau G, Sobnangou JJ, Aurenche C. et al. Viral markers of hepatitis B, C and D and HB vaccination status of a health care team in a rural district of Cameroon. Med Trop. 2011;71:201\u20132.", "ArticleIdList": ["21695887"]}, {"Citation": "Sack FN, Noah Noah D, Zouha\u00efratou H, Mbanya D.. Prevalence of HBsAg and anti-HCV antibodies in homozygous sickle cell patients at Yaounde Central Hospital. Pan Afr Med J. 2013;14:40.", "ArticleIdList": ["PMC3612872", "23560123"]}, {"Citation": "Ashuntantang G, Ashuntantang GE, Njouom R, Kengne AP, Ngemhe AN, Kaze FF. et al. Incidence and potential risk factors for seroconversion to Hepatitis C positivity in patients on Maintenance Hemodialysis in Sub-Saharan Africa: A single center study. Health Sci Dis. 2013;14:10\u20135."}, {"Citation": "Ndjomou J, Kupfer B, Kochan B, Zekeng L, Kaptue L, Matz B.. Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon. J Med Virol. 2002;66:179\u201386.", "ArticleIdList": ["11782926"]}, {"Citation": "Ndjomou J, Pybus OG, Matz B.. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol. 2003;84:2333\u201341.", "ArticleIdList": ["12917453"]}, {"Citation": "Pasquier C, Njouom R, Ayouba A, Dubois M, Sartre MT, Vessi\u00e8re A. et al. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol. 2005;77:390\u20138.", "ArticleIdList": ["16173014"]}, {"Citation": "Iles JC, Njouom R, Foupouapouognigni Y, Bonsall D, Bowden R, Trebes A. et al. Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing. J Clin Microbiol. 2015;53:3155\u201364.", "ArticleIdList": ["PMC4572555", "26202126"]}, {"Citation": "Pouillot R, Lachenal G, Pybus OG, Rousset D, Njouom R.. Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon. Infect Genet Evol. 2008;8:676\u201381.", "ArticleIdList": ["18599380"]}, {"Citation": "Luma HN, Eloumou SAFB, Malongue A, Temfack E, Noah DN, Donfack-Sontsa O. et al. Characteristics of anti Hepatitis C Virus antibody positive patients in a hospital setting in Douala, Cameroon. Int J Infect Dis. 2016;45:35\u20138.", "ArticleIdList": ["26905319"]}, {"Citation": "Laurent C, Bourgeois A, Mpoudi M, Butel C, Mpoudi-Ngol\u00e9 E, Delaporte E.. HIV and hepatitis C virus coinfection, Cameroon. Emerg Infect Dis. 2007;13:514\u20136.", "ArticleIdList": ["PMC2725885", "17552122"]}, {"Citation": "Mbougua JBT, Laurent C, Kouanfack C, Bourgeois A, Ciaffi L, Calmy A. et al. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon. BMC Public Health. 2010;10:105.", "ArticleIdList": ["PMC2841671", "20193053"]}, {"Citation": "Njouom R, Sartre MT, Timba I, Nerrienet E, Tchendjou P, Pasquier C. et al. Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C. J Med Virol. 2008;80:2079\u201385.", "ArticleIdList": ["19040282"]}, {"Citation": "Njoya O, Ntchama L, Tagni M, Dang I, Kowo M.. Relapses in the treatment of genotype 2 viral hepatitis C, a cause of concern in the blacks. Indian J Gastroenterol. 2013;33:292.", "ArticleIdList": ["24105664"]}, {"Citation": "Njayou F, Moundipa P\uff0cTchana N, Ngadjui T, Tchouanguep F.. Inhibition of microsomal lipid peroxidation and protein oxidation by extracts from plants used in Bamun folk medicine (Cameroon) against hepatitis. Afr J Tradit Complement Altern Med. 2008;5:278\u20139.", "ArticleIdList": ["PMC2816548", "20161949"]}, {"Citation": "Galani T, Sahuc M-E, Njayou F, Deloison G, Mkounga P, Feudjou F. et al. Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. Front Microbiol. 2015;6:1\u20139.", "ArticleIdList": ["PMC4432692", "26029203"]}, {"Citation": "Marotta F, Chui DH, Jain S, Polimeni A, Koike K, Zhou L. et al. Effect of a fermented nutraceutical on thioredoxin level and TNF-alpha signalling in cirrhotic patients. J Biol Regul Homeost Agents. 2011;25:37\u201345.", "ArticleIdList": ["21382272"]}, {"Citation": "Galani Tietcheu BR, Sass G, Njayou NF, Mkounga P, Tiegs G, Moundipa FP.. Anti-Hepatitis C Virus Activity of Crude Extract and Fractions of Entada africana in Genotype 1b Replicon Systems. Am J Chin Med. 2014;42:853\u201368.", "ArticleIdList": ["25004879"]}, {"Citation": "Galani BRT, Sahuc M-E, Sass G, Njayou FN, Loscher C, Mkounga P. et al. Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro. Arch Virol. 2016;161:1169\u201381.", "ArticleIdList": ["26843184"]}, {"Citation": "Batista MN, Carneiro MB, Braga SCA, Rahal P.. Caffeine inhibits hepatitis C virus replication in vitro. Arch Virol. 2015;160:399\u2013407.", "ArticleIdList": ["25491197"]}, {"Citation": "Chen M, Lee M, Chuang J, Li Y, Ning S, Chen J. et al. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. Int J Mol Med. 2012;30:1021\u20138.", "ArticleIdList": ["PMC3573749", "22922731"]}, {"Citation": "Anggakusuma Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S. et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 2014;63:1137\u201349.", "ArticleIdList": ["23903236"]}]}], "History": [{"Year": "2017", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "14", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "12", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28191540", "PMC5290894", "10.1515/jtim-2016-0037", "jtim-2016-0037"]}}]}